Einfluss regulatorischer T-Zellen im Endometriumkarzinom auf das Gesamtüberleben und die Tumorprogression

T Kolben; M Mannewitz; L Hahn; S Meister; K Schnell; C Perleberg; D Anz; E Schmoeckel; A Burges; B Czogalla; A Hester; S Mahner; U Jeschke; M Kessler; S Corradini; F Trillsch; S Beyer

doi:10.1055/s-0041-1730506

Geburtshilfe und Frauenheilkunde, Table of Contents

Geburtshilfe Frauenheilkd 2021; 81(06): e26
DOI: 10.1055/s-0041-1730506

Gynäkologische Onkologie inkl. Senologie

Einfluss regulatorischer T-Zellen im Endometriumkarzinom auf das Gesamtüberleben und die Tumorprogression

T Kolben

^*Diese Autoren haben gleichermaßen zu dieser Arbeit beigetragen.

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

,

M Mannewitz

^*Diese Autoren haben gleichermaßen zu dieser Arbeit beigetragen.

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

,

L Hahn

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

,

S Meister

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

,

K Schnell

²Center of Integrated Protein Science Munich, Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany

,

C Perleberg

²Center of Integrated Protein Science Munich, Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany

,

D Anz

²Center of Integrated Protein Science Munich, Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany

,

E Schmoeckel

³Institute of Pathology, University Hospital, LMU Munich, Munich Germany

,

A Burges

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

,

B Czogalla

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

,

A Hester

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

,

S Mahner

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

,

U Jeschke

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

⁴University Hospital Augsburg, Department of Obstetrics and Gynecology, Augsburg, Germany

,

M Kessler

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

,

S Corradini

⁵University Hospital, LMU Munich, Department of Radiation-Oncology, Munich, Germany

,

F Trillsch

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

,

S Beyer

¹University Hospital, LMU Munich, Department of Obstetrics and Gynecology, Munich, Germany

› Author Affiliations

Abstract

Full Text

References

Literatur
1 de Jong RA, Leffers N, Boezen HM. et al: Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecologic oncology 114: 105-10, 2009; (01)
2 Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004; 10 (09) : 942-9.
3 Whiteside TL. : The role of regulatory T cells in cancer immunology. ImmunoTargets and therapy 4: 159-71, 2015;
4 Du L, Xiao X, Wang C. et al: Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells. Cancer science 102: 1272-80, 2011; (07)